Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
673,176
-
Share change
-
-206,298
-
Total reported value
-
$262,000
-
Price per share
-
$0.39
-
Number of holders
-
10
-
Value change
-
-$79,909
-
Number of buys
-
4
-
Number of sells
-
5
Institutional Holders of CHINA PHARMA HLDGS INC - COM (CPHI) as of Q1 2022
As of 31 Mar 2022,
CHINA PHARMA HLDGS INC - COM (CPHI) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
673,176 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, TWO SIGMA ADVISERS, LP, MILLENNIUM MANAGEMENT LLC, Virtu Financial LLC, HRT FINANCIAL LP, TWO SIGMA SECURITIES, LLC, UBS Group AG, Joseph P. Lucia & Associates, LLC, and FIRST COMMUNITY TRUST NA.
This page lists
10
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.